We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+6.54%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.87%
AUM
$118B
AUM Growth
+$8.21B
Cap. Flow
+$1.08B
Cap. Flow %
0.91%
Top 10 Hldgs %
16.3%
Holding
2,665
New
135
Increased
1,412
Reduced
606
Closed
93

Sector Composition

Rank Sector Weight
1 Technology 16.35%
2 Financials 15.6%
3 Healthcare 12.81%
4 Consumer Discretionary 10.96%
5 Communication Services 9.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UBNK
2001
DELISTED
United Financial Bancorp, Inc.
UBNK
$399K ﹤0.01%
22,638
FBNC icon
2002
First Bancorp
FBNC
$2.6B
$398K ﹤0.01%
11,258
MNTA
2003
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$398K ﹤0.01%
28,496
FOMX
2004
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$397K ﹤0.01%
66,134
-40,178
-38% -$242K
CBZ icon
2005
CBIZ
CBZ
$2.99B
$397K ﹤0.01%
25,695
PDLI
2006
DELISTED
PDL BioPharma, Inc.
PDLI
$392K ﹤0.01%
143,165
+5,293
+4% +$16.3K
IRT icon
2007
Independence Realty Trust
IRT
$3.92B
$391K ﹤0.01%
38,794
+2,593
+7% +$26.7K
EGOV
2008
DELISTED
NIC Inc
EGOV
$388K ﹤0.01%
23,362
-10,714
-31% -$181K
IPCC
2009
DELISTED
Infinity Property & Casualty C
IPCC
$388K ﹤0.01%
3,658
AG icon
2010
First Majestic Silver
AG
$7.41B
$382K ﹤0.01%
56,477
PLOW icon
2011
Douglas Dynamics
PLOW
$1.02B
$378K ﹤0.01%
9,998
RSO
2012
DELISTED
Resource Capital Corp.
RSO
$378K ﹤0.01%
40,314
+40,220
+42,787% +$402K
PBR icon
2013
Petrobras
PBR
$125B
$377K ﹤0.01%
+36,626
New +$374K
HRTG icon
2014
Heritage Insurance Holdings
HRTG
$889M
$377K ﹤0.01%
20,900
+2,300
+12% +$38.2K
ENSG icon
2015
The Ensign Group
ENSG
$10.4B
$373K ﹤0.01%
17,943
+559
+3% +$12K
SMB icon
2016
VanEck Short Muni ETF
SMB
$312M
$372K ﹤0.01%
+21,587
New +$376K
IVW icon
2017
iShares S&P 500 Growth ETF
IVW
$73.8B
$372K ﹤0.01%
9,740
+5,220
+115% +$195K
MGRC icon
2018
McGrath RentCorp
MGRC
$2.81B
$371K ﹤0.01%
7,900
FIT
2019
DELISTED
Fitbit, Inc. Class A common stock
FIT
$371K ﹤0.01%
64,990
+20,243
+45% +$129K
EBF icon
2020
Ennis
EBF
$552M
$368K ﹤0.01%
17,744
+2
+0% +$40
KALA icon
2021
KALA BIO
KALA
$14.1M
$366K ﹤0.01%
8
-9
-53% -$421K
NMIH icon
2022
NMI Holdings
NMIH
$3.33B
$365K ﹤0.01%
21,499
ADAM
2023
Adamas Trust
ADAM
$815M
$365K ﹤0.01%
14,779
+1,057
+8% +$26.6K
MTRN icon
2024
Materion
MTRN
$4.39B
$364K ﹤0.01%
7,499
CTT
2025
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$363K ﹤0.01%
27,684
+14,084
+104% +$182K

Similar funds

UBS AM's Q4 2017 Portfolio in Review

As of Q4 2017, UBS AM held 2,665 positions worth $118B, up 7.5% from $110B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS AM's Q4 2017 filing shows 135 new, 1,412 increased, 606 reduced and 93 closed positions. Its largest new stake was Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share: 2,522,917 shares worth $29.2M. The largest sale was Celgene Corp, an estimated $228M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • UBS AM's largest Q4 2017 buy was Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share: 2,522,917 shares worth $29.2M.
  • UBS AM added most to NetEase in Q4 2017, an estimated $383M increase.
  • UBS AM's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $228M.
  • UBS AM fully exited CR Bard Inc. in Q4 2017, selling an estimated $67.9M.
  • UBS AM's ten largest holdings make up 16% of its $118B portfolio in Q4 2017.
  • UBS AM opened 135 new positions and closed 93 in Q4 2017.
  • UBS AM's portfolio value rose 7.5% quarter-over-quarter to $118B.

Based on UBS AM's 13F filing for Q4 2017, filed 9 Feb 2018.